Mauna Kea Technologies S.A. (ALMKT.PA)
Mauna Kea Technologies S.A. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Paris, IF, FR. The stock last traded at $0.15, down 2.20% on the session, giving a market capitalisation of $29.5M. Its beta of 0.94 implies it has historically moved less than the broad market.
Mauna Kea Technologies SA operates as a medical device enterprise, producing and distributing its offerings throughout Europe and worldwide. Its product line serves various medical specialties such as gastroenterology, pulmonology, and urology. Central to its portfolio is Cellvizio, an in vivo cellular imaging platform that delivers real-time data. This innovative system assists medical practitioners in tracking disease evolution, evaluating immediate physiological responses, delineating ambiguous tissue areas, and providing guidance during surgical procedures. Founded in 2000, the company's headquarters are situated in Paris, France.
Mauna Kea Technologies S.A. is most often compared with the following Healthcare names: